GL vs SNDX · P/E 10, rev $3.16B vs rev $137.7M
Globe Life Inc (GL) versus Syndax Pharmaceuticals Inc (SNDX) — a side-by-side from cached financials, not a winner call.
Globe Life Inc (GL) is a insurance - life company listed on US.
Syndax Pharmaceuticals Inc (SNDX) is a biotechnology company listed on US.
Latest reported GL revenue for 2026-06-30 was $3.16B. Net income was $558.3M. GL currently screens at market cap $10.26B and trailing P/E 10.1.
Latest reported SNDX revenue for 2026-06-30 was $137.7M. Net income was -$92.0M. SNDX currently screens at market cap $774.4M.
GL currently screens at market cap $10.26B and trailing P/E 10.1. SNDX currently screens at market cap $774.4M.
Not investment advice. Open the GL and SNDX stock pages for the full models.
Not investment advice.